HariSConjeevaramMDMSc

Biliary Tract Disease, Hepatology & Liver Transplantation

Professor, Internal Medicine, University of Michigan Medical School

Dr. Conjeevaram is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1500 East Medical Center Dr
3912 Taubman Center
Ann Arbor, MI 48109
Phone+1 844-233-0433

The MetroHealth System/Case Western Reserve UniversityFellowship, Gastroenterology, 1991 - 1992
The MetroHealth System/Case Western Reserve UniversityFellowship, Gastroenterology, 1989 - 1991
The MetroHealth System/Case Western Reserve UniversityResidency, Internal Medicine, 1986 - 1989
Madras Medical CollegeClass of 1984

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

PubMed

85 citations
Clinical course and management of inflammatory bowel disease after liver transplantation
Alex S. Befeler, Trevor Lissoos, Thomas D. Schiano, H Conjeevaram, K. Dasgupta
Transplantation. 1998-02-15
3225 citations
A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C
Chun-Tao Wai, Joel K. Greenson, Robert J. Fontana, John D. Kalbfleisch, Jorge A. Marrero
Hepatology. 2003-08-01
556 citations
Features and outcomes of 899 patients with drug-induced liver injury: The DILIN prospective study
Naga Chalasani, Herbert L. Bonkovsky, Robert J. Fontana, William M. Lee, Andrew Stolz
Gastroenterology. 2015-06-01

Journal Articles

A Deeper Look at the Small Bowel: Training Pathways in Video Capsule Endoscopy and Device-Assisted Enteroscopy
Michael D Rice, Hari S Conjeevaram, Sameer D Saini, Andrew J Read, Digestive Diseases and Sciences

Studies Show Effectiveness of Combo Treatment for HCV Patients with, Without CirrhosisMay 5th, 2015

Effects Of Recombinant Human Leptin In Nonalcoholic Fatty Liver Disease (NAFLD)National Institute Of Diabetes And Digestive And Kidney Diseases2011–2012
Pioglitazone In HEP C: A Randomized, Double Blind, Placebo-Controlled StudyNational Center For Research Resources2007
Fenofibrate For Treatment Of NASH: A Random, Double Blind, Placebo-Ctrld StudyNational Center For Research Resources2005–2007
Fenofibrate For The Treatment Of Patients With NASHNational Institute Of Diabetes And Digestive And Kidney Diseases2006
Pioglitazone In Hepatitis C: A Randomized, Double Blind, Placebo-Controlled StudNational Center For Research Resources2006
Virahep-CNational Center For Research Resources2005–2006
Predictors Of Histologic Severity In Non-Alcoholic Fatty Liver Disease (NAFLD)National Center For Research Resources2004–2005
Virahep-C: A Multi-Center, Collaborative Clinical TrialNational Center For Research Resources2004
Dietary Intervention On Histologic Improvement In Non-Alcoholic SteatohepatitisNational Center For Research Resources2004
Virahep-C Clinical CenterNational Institute Of Diabetes And Digestive And Kidney Diseases2001–2004
Combined Ribavirin And Intron-A In Pediatric Patients With Chronic Hepatitis CNational Center For Research Resources2000–2002